6 hours Ago By ABMN Staff
Geneos Wealth Management Inc. lessened its holdings in DocuSign, Inc. ( NASDAQ:DOCU – Free Report ) by 46.
0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,872 shares of the company’s stock after selling 1,597 shares during the period. Geneos Wealth Management Inc.
’s holdings in DocuSign were worth $168,000 as of its most recent SEC filing. Several other hedge funds and other institutional investors have also made changes to their positions in the business. Toronto Dominion Bank raised its position in DocuSign by 30.
3% in the third quarter. Toronto Dominion Bank now owns 26,159 shares of the company’s stock valued at $1,624,000 after purchasing an additional 6,081 shares during the period. Inspire Investing LLC acquired a new position in DocuSign during the 3rd quarter worth approximately $911,000.
Charles Schwab Investment Management Inc. lifted its position in DocuSign by 1.2% during the 3rd quarter.
Charles Schwab Investment Management Inc. now owns 1,328,355 shares of the company’s stock worth $82,478,000 after acquiring an additional 16,014 shares in the last quarter. International Assets Investment Management LLC boosted its holdings in DocuSign by 5,660.
8% in the 3rd quarter. International Assets Investment Management LLC now owns 438,914 shares of the company’s stock worth $27,252,000 after acquiring an additional 431,295 shares during the period. Finally, Quantinno Capital Management LP grew its position in DocuSign by 39.
5% in the third quarter. Quantinno Capital Management LP now owns 201,546 shares of the company’s stock valued at $12,514,000 after acquiring an additional 57,104 shares in the last quarter. Institutional investors and hedge funds own 77.
64% of the company’s stock. Insider Activity In related news, Director Peter Solvik sold 10,000 shares of the business’s stock in a transaction that occurred on Friday, January 10th. The stock was sold at an average price of $91.
26, for a total transaction of $912,600.00. Following the completion of the transaction, the director now owns 150,253 shares in the company, valued at $13,712,088.
78. The trade was a 6.24 % decrease in their position.
The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink . Also, CEO Allan C. Thygesen sold 7,763 shares of the stock in a transaction on Monday, December 2nd.
The stock was sold at an average price of $80.54, for a total value of $625,232.02.
Following the completion of the sale, the chief executive officer now directly owns 100,062 shares in the company, valued at $8,058,993.48. This represents a 7.
20 % decrease in their ownership of the stock. The disclosure for this sale can be found here . In the last three months, insiders sold 685,773 shares of company stock valued at $66,032,726.
Company insiders own 1.66% of the company’s stock. Analyst Ratings Changes Check Out Our Latest Stock Analysis on DocuSign DocuSign Price Performance DocuSign stock opened at $95.
85 on Friday. DocuSign, Inc. has a 12 month low of $48.
70 and a 12 month high of $107.86. The company has a fifty day moving average price of $90.
73 and a two-hundred day moving average price of $72.41. The company has a market cap of $19.
36 billion, a PE ratio of 19.76, a P/E/G ratio of 8.30 and a beta of 0.
88. DocuSign Company Profile ( Free Report ) DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Recommended Stories Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DocuSign, Inc. ( NASDAQ:DOCU – Free Report ).
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter ..
